RAC 3.33% $1.55 race oncology ltd

Cardioprotection thread, page-694

  1. 6,692 Posts.
    lightbulb Created with Sketch. 841

    If you bother to read it is a new trial of it gets through which step do you think it will be places in health insurance step program…. You do realise at the current numbers RAC is running it is something like 20x (and that’s being nice on my part) the cost per dose

    Other drugs out there still looking at the new cardiovascular protection world of AML could be the same price….. Who knows but so far this Losartan has a compelling case for a competition trial….

    But once again - DONT EVEN WORRY ABOUT IT!!! To the moon it’s a definite
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.